Guo, Lixin http://orcid.org/0000-0001-6863-1798
Li, Li
Yu, Qiurong
Wang, Na
Chen, Jun
Wang, Zhiquan
Ding, Yuchen
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 31 January 2022
Accepted: 20 April 2022
First Online: 18 May 2022
Funding
: This post-marketing safety study was funded by Eli Lilly and Company. Eli Lilly and Company provided funding for medical writing, editorial support, and publication fees.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Lixin Guo, Li Li, Qiurong Yu, Na Wang, Jun Chen, Zhiquan Wang, and Yuchen Ding. All authors contributed to the first draft and reviewed and commented on revisions until this manuscript was finalized. All authors read and approved the final manuscript.
: Editorial assistance in the preparation of this article was provided by Sharon Suntag, Chrysi Petraki, and Andrew McCulloch of IQVIA. Support for this assistance was funded by Eli Lilly and Company. The authors would like to thank Yihua Wang (MD, Eli Lilly and Company), Xiao Ma (PhD, Eli Lilly and Company), Yuying Deng (PhD, Eli Lilly and Company), Jinnan Li (MPH, Eli Lilly and Company) for review and critical suggestions for improvement.
: Zhiquan Wang and Yuchen Ding are employees of and hold equity in Eli Lilly and Company. Lixin Guo, Li Li, Qiurong Yu, Na Wang, and Jun Chen declare that they have nothing to disclose.
: This non-interventional, post-marketing safety study was submitted to ethical review boards for approval whenever required by local law. Regardless of local law, all primary data collection observational studies were submitted to at least one independent body for review and to confirm that the study is considered non-interventional. Additional information on the Ethics Review Board is provided in ESM Appendix 2. Regulatory authorities were notified, and approval was sought as required by local laws and regulations. This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki (1964 and its later amendments) and that are consistent with good clinical practices and applicable laws and regulations of China.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.